Co-Authors
This is a "connection" page, showing publications co-authored by Claudio Mastroianni and Francesco Alessandri.
Connection Strength
1.234
-
Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
Score: 0.224
-
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
Score: 0.223
-
Is Albumin Predictor of Mortality in COVID-19? Antioxid Redox Signal. 2021 07 10; 35(2):139-142.
Score: 0.222
-
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
Score: 0.222
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
Score: 0.060
-
Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge. J Gen Intern Med. 2021 06; 36(6):1702-1707.
Score: 0.059
-
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
Score: 0.058
-
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II). Cardiovasc Diabetol. 2020 10 01; 19(1):164.
Score: 0.057
-
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract. 2020 Nov; 169:108454.
Score: 0.056
-
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec; 30(12):6808-6817.
Score: 0.056